TH 24 ANNUAL SYMPOSIUM OF THE
INTERNATIONAL CANNABINOID RESEARCH SOCIETY
BAVENO
ITALY
JUNE 28 - JULY 3, 2014
PRELIMINARY PROGRAMME
TH 24 ANNUAL
SYMPOSIUM OF THE
INTERNATIONAL CANNABINOID RESEARCH SOCIETY
BAVENO
JUNE 28 – JULY 3, 2014
ICRS Sponsors
Government Sponsors
National Institute on Drug Abuse
Non- Profit Organization Sponsors
Kang Tsou Memorial Fund
2014 Symposium on the Cannabinoids
Conference Coordinators
Cecilia Hillard, Ph.D. Daniela Parolaro, Ph.D. Tiziana Rubino, Ph.D. Ethan Russo, M.D. Jason Schechter, Ph.D.
Programme Committee
Steve Alexander, Ph.D. Tiziana Bisogno, Ph.D. Heather B Bradshaw, Ph.D. Vincenzo Di Marzo, Ph.D. Michelle Glass, Ph.D. Matthew Hill, Ph.D Mary Lynch, Ph.D. Mauro Maccarrone, Ph.D. . Sean McAllister, Ph.D. Daniela Parolaro, Ph.D. Roger G. Pertwee, M.A., D.Phil., D.Sc. Julian Romero Paredes, Ph.D. Tiziana Rubino, Ph.D. Ethan Russo, M.D. Miriam Schneider, Ph.D. Michelle Sexton, N.D. Ryan Vandrey, Ph.D. Jenny Wiley, Ph.D.
Committee on Awards
Steve Kinsey, Ph.D., Chair Sachin Patel, M.D., Ph.D.
Student Award Committee Chair
Eliot Gardner, Ph.D.
Mechoulam Award Committee
Francis Barth, Ph.D. Benjamin Cravatt, Ph.D. Vincenzo Di Marzo, Ph.D. Cecilia Hillard, Ph.D. Allyn Howlett, Ph.D. John Huffman, Ph.D. George Kunos, M.D., Ph.D. Gerard Le Fur, Ph.D. Aron Lichtman, Ph.D. Ken Mackie, M.D. Alex Makriyannis, Ph.D. Roger Pertwee, D.Phil, D.Sc. Raj Razdan, Ph.D. Patti Reggio, Ph.D. Murielle Rinaldi- Carmona, Ph.D.
2014 ICRS Board of Directors
Executive Director Cecilia Hillard, Ph.D.
President Ethan Russo, M.D.
President- Elect Stephen Alexander, Ph.D.
Past President Jenny Wiley, Ph.D.
Secretary Steve Kinsey, Ph.D.
Treasurer Mary Abood, Ph.D.
International Secretary Roger Pertwee, M.a., D.Phil, D.Sc.
Newsletter Editor Brian Thomas, Ph.D.
Student Representative Tiffany Lee
Managing Director Jason Schechter, Ph.D.
Registration: June 28th, 2014 (16.00 – 18.00)
Welcome Reception: 18.30 – 20.00
Day 1 Sunday, June 29th
7.00 Breakfast
8.15 Welcome and Opening Remarks
Oral Session 1. Cannabinoids and Pathophysiology
CHAIRS: STEVE ALEXANDER AND MAURO MACCARRONE
Fabio Arturo Iannotti, STUDY OF THE EXPRESSION PROFILE Enrico Mazzarella, AND PHARMACOLOGICAL ROLE OF THE Ester Pagano, CB1 RECEPTOR IN DUCHENNE 8.30 MUSCULAR DYSTROPHY (DMD) 1 Elisabetta Gazzero, MUSCLES: A NEW OPPORTUNITY TO Raffaele Capasso REINFORCE MUSCLE REPAIR AND and Vincenzo Di Marzo LOCOMOTOR ACTIVITY
PALMITOYLETHANOLAMIDE IN A RAT MODEL OF OSTEOARTHRITIS: Giulia Donvito ITS ANTI-INFLAMMATORY AND 8.45 2 and Barbara Costa ANTINOCICEPTIVE EFFECTIVENESS IN COMPARISON WITH NIMESULIDE AND ACETAMINOPHEN
Marie-Chantal Larose, Caroline Turcotte, MECHANISMS OF HUMAN Cyril Martin, EOSINOPHIL MIGRATION INDUCED 9.00 3 Véronique Provost, BY THE ENDOCANNABINOID Michel Laviolette 2-ARACHIDONOYL-GLYCEROL and Nicolas Flamand
Irina Bronova, PERIPHERAL TARGETING OF Katalin Erdelyi, Alex CB1 CANNABINOID RECEPTORS 9.15 4 Makriyannis, Pal Pacher PROTECTS FROM RADIATION- and Evgeny Berdyshev INDUCED PULMONARY FIBROSIS
Daniel J. Hermanson, ENDOCANNABINOID Shu Xu, Naoko Brown, AUGMENTATION BY SUBSTRATE- 9.30 Jeffrey Reese, SELECTIVE COX - 2 INHIBITORS: 5 Sachin Patel MECHANISM AND IN VIVO PROBE and Lawrence J. Marnett DEVELOPMENT
James Brodie, THE THERAPEUTIC HANDSHAKE: 9.45 Vincenzo Di Marzo CRAFTING MEDICINES FOR 6 and Geoffrey Guy COMPLEX MALADIES
10.00 Coffee Break
PROTECTIVE ROLE OF Shimon Ben-Shabat, THE CANNABINOID RECEPTOR Shiela Hauzner, 10.30 SYSTEM IN AN IN VITRO MODEL 7 Mor Cohen OF AGE-RELATED MACULAR and Elie Beit-Yannai DEGENERATION (AMD)
Ariana Foinquinos, Katharina Schimmel, Jan THE CANNABINOID-1 RECEPTOR 10.45 8 Fiedler, Thomas Thum IN CARDIAC FIBROSIS and Sandor Batkai
THE ENDOCANNABINOID Kevin Wilhelmsen, N-ARACHIDONOYL DOPAMINE Samira Khakpour, 11.00 (NADA) AND WIN55,212-2 MODULATE 9 Alphonso Tran THE INFLAMMATORY ACTIVATION and Judith Hellman OF HUMAN ENDOTHELIAL CELLS
Tamás Bíró, Attila Oláh, NOVEL INHIBIORS OF FATTY Dóra Bodnár, Lídia ACID AMIDE HYDROLASE Ambrus, Attila G. EXERT REMARKABLE ANTI- 11.15 Szöllősi, Nikolett Vasas, 10 INFLAMMATORY EFFECTS BOTH IN Judit Szabó-Papp, Ralf VITRO IN HUMAN KERATINOCYTES Paus, Michael Soeberdt AND IN VIVO IN NC/TND MICE and Christoph Abels
Saja Baraghithy, Reem Smoum, STIMULATION OF BONE MASS 11.30 Malka Attar-Namdar, BY A NOVEL METHYLATED 11 Raphael Mechoulam OLEOYL SERINE DERIVATIVE and Itai Bab
12.00 Lunch
13.00 - 15.00 Poster Session 1 P1
Presidential Plenary Speaker
CANNABINOIDS REVISITED? NEW TARGETS, CHEMISTRY AND PLANT SOURCES
15.00 Giovanni Appendino, Ph.D. Professor of Organic Chemistry, Università del Piemonte Orientale Department of Pharmaceutical Sciences, Novara, Italy
16.00 Coffee Break
Oral Session 2. Pain and TRPs
CHAIRS: TIZIANA BISOGNO AND MARY LYNCH
Jenny Wilkerson, DIACYLGLYCEROL LIPASE Sudeshna Ghosh, BETA: NEW EVIDENCE 16.30 Ku-Lung Hsu, 12 FOR INFLAMMATORY AND Benjamin F. Cravatt NEUROPATHIC PAIN RELIEF IN MICE and Aron H. Lichtman
POSITIVE ALLOSTERIC Richard A. Slivicki, MODULATION OF CB1 WITH GAT211 Liting Deng, Pushkar M. SUPPRESSES PACLITAXEL-INDUCED Kulkarni, Maria Cascio, 16.45 NEUROPATHIC PAIN WHILE 13 Roger G. Pertwee, BYPASSING UNWANTED SIDE Ganesh A. Thakur and EFFECTS OF CB1 RECEPTOR Andrea G. Hohmann ACTIVATION
Miren-Josune Canduela, ANATOMY AND FUNCTIONAL Juan-Luis Mendizabal- ROLE OF THE TRANSIENT RECEPTOR Zubiaga, Amanda Sierra, POTENTIAL VANILLOID TYPE 1 IN 17.00 Naiara Royo, 14 THE DENTATE GYRUS OF A Sara Peñasco, Leire KAINATE-INDUCED SEIZURES Reguero, Nagore Puente MOUSE MODEL and Pedro Grandes
OVEREXPRESSION OF TRPV1 IN HEK Heather B Bradshaw, CELLS DRIVES DRAMATIC CHANGES Emma Lieshman, IN BASAL ENDOCANNABINOIDS AND 17.15 15 Jordyn M Stuart RELATED LIPIDS WHICH ARE and Mark Connor POTENTIATED WITH STIMULATION BY CAPSAICIN
Oral Session 3. Developmental
CHAIRS: TIZIANA RUBINO AND SARA JANE WARD
Valerio Chiurchiù, ANANDAMIDE REGULATES Alessandro Leuti, MATURATION AND FUNCTION 17.30 16 Emanuela Talamonti OF HUMAN MONOCYTE-DERIVED and Mauro Maccarrone DENDRITIC CELLS
LEARNING UNDER Maria Morena, Andrea STRESS DIFFERENTIALLY Peloso, Viviana Trezza, 17.45 AFFECTS CANNABINOID 17 Matthew N. Hill MODULATION OF SPATIAL and Patrizia Campolongo MEMORY RETRIEVAL IN RATS
Piray Atsak, Daniela Hauer, THE ROLE OF ENDOCANNABINOID Patrizia Campolongo, SIGNALING IN MEDIATING EFFECTS 18.00 18 Gustav Schelling, OF SEVERAL STRESS SYSTEMS IN Raquel V Fornari MEMORY CONSOLIDATION and Benno Roozendaal
Andrea Martella, Rosa Maria Sepe, FUNCTIONAL CHARACTERIZATION Cristoforo Silvestri, OF THE ENDOCANNABINOID SYSTEM 18.15 19 Oliana Carnevali, DURING ZEBRAFISH (DANIO RERIO) Paolo Sordino EMBRYONIC DEVELOPMENT and Vincenzo Di Marzo
EFFECTS OF DELETIONS IN FAAH Emma Leishman, ON THE ENDOCANNABINOID 18.30 Ben Cornett, Ken Mackie AND WIDE-RANGING-RELATED 20 and Heather B Bradshaw LIPIDOME IN EIGHT REGIONS OF THE MOUSE BRAIN
Oral Session 4. Cannabinoids and Cancer
CHAIRS: TIZIANA RUBINO AND SARA JANE WARD
Paula Morales, NOVEL CB2 SELECTIVE Sandra Blasco-Benito, CANNABINOID-ORTHOQUINONES María Gómez-Cañas, EFFECTIVE FOR THE TREATMENT 18.45 Pilar Goya, 21 OF TRIPLE NEGATIVE BREAST Javier Fernández-Ruiz, CANCER AND LACKING Cristina Sánchez NON-TUMOR CELL TOXICITY and Nadine Jagerovic
Christopher J. Fowler, IDENTIFYING POTENTIAL Jenny Häggström, UPSTREAM REGULATORS OF 19.00 22 Mariateresa Cipriano THE ENDOCANNABINOID SYSTEM and Peter Hammarsten IN PROSTATE CANCER
19.30 Dinner
Day 2 Monday, June 30th
7.00 Breakfast
Oral Session 5. Cannabinoid Receptors and Signaling
CHAIRS: MICHELLE GLASS AND NEPHI STELLA
BETA-ARRESTIN2 APPEARS TO MEDIATE THE ACTIVITY Chris Breivogel 8.30 OF CANNABINOIDS IN FEMALE 23 and Ankita Gupta MICE IN A MANNER THAT DIFFERS FROM MALES
Nilushi Karunaratne, Paul J White, Stewart SIGNALLING PROFILE OF CRIP1a: 8.45 Fabb, Meritxell Canals, G - PROTEIN ACTIVATION AND 24 Mark Connor SIGNAL TRANSDUCTION and Daniel T Malone
Etienne Hebert- Chatelain, Tifany Desprez, Edgar Soria, Luigi Bellocchio, Anna Delamarre, Arnau Busquets-Garcia, Laurie MITOCHONDRIAL CANNABINOID Robin, Nagore Puente, RECEPTORS MEDIATE SPECIFIC 9.00 25 Jean-William Dupuy, EFFECTS OF CANNABINOIDS VIA Uzaskun Elezgarai, SOLUBLE ADENYLYL CYCLASE (sAC) Rodrigue Rossignol, Federico Massa, Pedro Grandes, Giovanni Bénard and Giovanni Marsicano
MOLECULAR DYNAMICS STUDY OF Derek M. Shore, A CB1 ENDOGENOUS ALLOSTERIC Diane L. Lynch, 9.15 MODULATOR, LIPOXIN A4: DYNAMIC 26 Michael C. Pitman BEHAVIOR IN A LIPID BILAYER AND and Patricia H. Reggio ENTRANCE INTO THE CB1 RECEPTOR
Alipi V. Naydenov, GENETIC RESCUE OF Marja Sepers, CB1 RECEPTORS ON MEDIUM Katie Swinney, SPINY NEURONS PREVENTS 9.30 27 Lynn Raymond, LOSS OF EXCITATORY STRIATAL Richard Palmiter SYNAPSES BUT NOT MOTOR and Nephi Stella PHENOTYPE IN R6/2 MICE
Martin Kaczocha, FATTY ACID BINDING Matthew W. Elmes, PROTEINS (FABPS) William T. Berger, 9.45 ARE INTRACELLULAR CARRIERS 28 KwanNok Leung, FOR ∆9-TETRAHYDROCANNABINOL Iwao Ojima (THC) AND CANNABIDIOL (CBD) and Dale G. Deutsch
Michelle Glass, FUNCTIONAL SELECTIVITY IN 10.00 Courtney M Breen CB1R PHARMACODYNAMICS – 29 and Mark Connor OCCUPANCY, EFFICACY AND TIME
10.15 Coffee Break
Oral Session 6. Cannabis Use and Abuse Issues
CHAIRS: ZIVA COOPER AND RYAN VANDREY
Maju Mathew Koola, Hailey E. Turner, CANNABIS WITHDRAWAL IN 10.45 Deanna L. Kelly, Fang 30 ADULTS WITH MOOD DISORDERS Liu, Jared A. Linthicum and David A. Gorelick
Zheng-Xiong Xi, Pretal Muldoon, EFFECTS OF Xiao-Fei Wang, Guo- Δ8-TETRAHYDROCANNABIVARIN 11.00 Hua Bi, M. Imad Damaj, (Δ8-THCV) ON APPETITIVE 31 Aron H. Lichtman, EFFECTS OF COCAINE Roger G. Pertwee AND NICOTINE IN RODENTS and Eliot L. Gardner
Ryan Vandrey, Edward J EFFECT OF ROOM VENTILATION ON Cone, John M. Mitchell, THE PHARMACODYNAMIC AND Evan S. Herrmann, 11.15 PHARMACOKINETIC EFFECTS OF 32 George E. Bigelow, SECONDHAND CANNABIS SMOKE Charles LoDico EXPOSURE and Ron Flegel
ADVERSE PEER-EXPERIENCES Miriam Schneider, THROUGHOUT ADOLESCENCE Chris M. Friemel, IN MALE RATS PERSISTENTLY 11.30 33 Laura Bindila ALTER ETHANOL INTAKE AND and Beat Lutz ENDOCANNABINOID SIGNALING IN LATER LIFE
NALTREXONE MAINTENANCE M. Haney, G. Bedi REDUCES CANNABIS 11.45 34 and Z.D. Cooper SELF-ADMINISTRATION IN CANNABIS SMOKERS
12.00 Lunch
12.30 NIDA Career InfoSession
Oral Session 6 (Cont.) Cannabis Use and Abuse Issues
CHAIRS: ZIVA COOPER AND RYAN VANDREY
Antonia Manduca, SOCIAL REWARD IS MEDIATED Patrizia Campolongo, BY INTERACTING OPIOID AND Louk J.M.J. 14.00 CB1 CANNABINOID RECEPTORS 35 Vanderschuren, IN THE NUCLEUS ACCUMBENS Olivier J. Manzoni CORE IN ADOLESCENT RATS and Viviana Trezza
Daniel Ziemianski, Rielle Capler, CANNABIS IN MEDICINE: A Rory Tekanoff, NATIONAL EDUCATIONAL NEEDS 14.15 36 Anais Lacasse, ASSESSMENT AMONG CANADIAN Francesca Luconi PHYSICIANS and Mark A. Ware
Jordyn Stuart, ACTIVITY OF SYNTHETIC Samuel D. Banister, CANNABINOID DRUGS OF ABUSE Courtney Breen, 14.30 AT G PROTEIN COUPLED CB 37 Michelle Glass, RECEPTORS AND CANNABINOID- Michael Kassiou SENSITIVE ION CHANNEL and Mark Connor
EFFECTS OF CANNABIS ON THE Ziva D. Cooper, SUBJECTIVE-EFFECT RATINGS 14.45 Richard W. Foltin 38 AND PHARMACOKINETICS and Margaret Haney OF SMOKED COCAINE
Philippe Lucas, Zachary Walsh, Kim Crosby, SUBSTITUTION EFFECT IN 628 Robert Callaway, Lynne, MEDICAL CANNABIS PATIENTS; Belle-Isle, Rielle Capler, 15.00 RESULTS FROM THE CANNABIS 39 Susan Holtzman, Bob ACCESS FOR MEDICAL PURPOSES Kay, Jamie Marshall, SURVEY (CAMPS) Trevor Stratton and Michael Woodsworth
15.15 Coffee Break
Oral Session 7. Metabolism
CHAIRS: RANGAN MAITRA AND JENNY WILEY
Livio Luongo, Luigia LEPTIN-CONTROLLED Cristino, Roberta OREXIN/ENDOCANNABINOID Imperatore, Serena INTERACTIONS IN THE MOUSE Boccella, Stefania 15.45 PERIAQUEDUCTAL GREY: ROLE IN 40 Petrosino, Francesca THE REGULATION OF THE Guida, Piero Orlando, DESCENDING ANTINOCICEPTIVE Vincenzo Di Marzo PATHWAY and Sabatino Maione
IN VIVO EVALUATION OF THE Rangan Maitra, Alan PERIPHERALLY SELECTIVE CB1 Fulp, Herbert Seltzman, 16.00 RECEPTOR ANTAGONIST RTI-13329- 41 Yanan Zhang 2 IN A MOUSE MODEL OF DIET- and Timothy Fennell INDUCED WEIGHT GAIN
Natalia Murataeva, WHERE’S MY ENTOURAGE? THE 16.15 Alex Straiker 42 CURIOUS CASE OF 2-OG AND 2-LG and Ken Mackie
Emma Leishman, NAPE-PLD DELETION VIA AN Ben Cornett, ALTERNATIVE MECHANISM 16.30 43 Ken Mackie and DRIVES SIGNIFICANT DECREASES Heather B Bradshaw IN AEA IN THE MOUSE BRAIN
Oral Session 8. CNS and Psychiatric Issues
CHAIRS: MATT HILL AND DANIELA PAROLARO
Rebecca J. Bluett, Brian Shonesy, Daniel Hermanson, Nolan BIDIRECTIONAL MANIPULATIONS Hartley, Teniel Ramikie, OF 2-ARACHIDONOYLGLYCEROL 16.45 44 Lawrence Marnett, CONTENT MODULATE ANXIETY- Danny Winder, LIKE BEHAVIORS Roger Colbran and Sachin Patel
Zach Walsh, CANNABIS, ANXIETY, AND PAIN: Kim Crosby, 17.00 THE IMPORTANCE OF COPING 45 Kelsey Lozenski STYLE and Susan Holtzman
17.15 Snack Break
Luciana Leo, Suellen ENDOGENOUS CB1 Almeida-Corrêa, Claudio ALLOSTERIC ENHANCER 17.45 Canetti, Olavo Amaral, 46 BALANCES AGE-RELATED Fernando Bozza COGNITIVE ALTERATIONS and Fabricio Pamplona
Andras Bilkei-Gorzo, Onder Albayram, Anastasia Piyanova, Mona Dvir-Ginzberg, Δ9-THC RESTORES AGE-RELATED 18.00 47 Astrid Draffehn, CHANGES IN THE BRAIN Itai Bab, Joachim Schultze, Ildiko Racz and Andreas Zimmer
Arnau Busquets-Garcia, Maria Gomis-González, Laura Cutando, Raj K. A PERIPHERAL Srivastava, Antonio ENDOCANNABINOID MECHANISM 18.15 Ortega-Álvaro, Luigi 48 Bellochio, Giovanni FOR STRESS-INDUCED AMNESIA Marsicano, Beat Lutz, Rafael Maldonado and Andrés Ozaita
PERSISTENT MICROGLIA ACTIVATION WITHIN THE Erica Zamberletti, PREFRONTAL CORTEX Marina Gabaglio, CONTRIBUTES TO THE 18.30 Pamela Prini, DEVELOPMENT OF THE 49 Tiziana Rubino DEPRESSIVE/PSYCHOTIC- and Daniela Parolaro LIKE PHENOTYPE INDUCED BY ADOLESCENT THC EXPOSURE IN RATS
A MEDICAL ETHNOGRAPHIC Michelle Sexton REPORT OF CANNABIS USE IN 18.45 50 and Dominic Corva PEDIATRIC INTRACTABLE EPILEPSY (IE) PATIENTS
19.00 Dinner - On Your Own
Day 3 Tuesday, July 1st
7.00 Breakfast
NIDA Symposium
TRP Channels: The only TR(i)P you can have on cannabinoids?
CHAIR: VINCENZO DI MARZO
ANATOMY AND FUNCTIONAL ROLE Pedro Grandes OF THE TRANSIENT RECEPTOR 8.15 Medicine and Dentistry POTENTIAL VANILLOID TYPE 1 IN N1 Basque Country University THE DENTATE GYRUS OF A KAINATE- Leioa, Spain INDUCED SEIZURES MOUSE MODEL
Thomas Voets MODULATION OF TEMPERATURE- 8.45 Laboratory of Ion Channel N2 Research (LICR) SENSITIVE TRP CHANNELS Leuven, Belgium
INTERACTIONS BETWEEN Vincenzo Di Marzo THE "ENDOCANNABINOIDOME" Endocannabinoid Research Group 9.15 Institute of Biomolecular Chemistry AND THE "TRPOME": A NEW "OME" N3 Consiglio Nazionale delle Ricerche FOR PHYTOCANNABINOIDS Pozzuoli, Italy AND LIPID MEDIATORS?
9.45 Coffee Break
Oral Session 9. Cannabinoid Genetics
CHAIRS: JAHAN MARCU AND ROGER PERTWEE
Kevin J. McKernan, Amir Zare, Lei Zhang, Jessica Spangler, EXOME SEQUENCING OF FAMILIAL Vasisht Tadigotla, Ted ATRIAL FIBRILLATION INFORMS 10.15 51 Foss, Christine Stanley, POSITIVE TREATMENT WITH Melissa Pulliam, CANNABIDIOL Robert W. Pulliam and Richard G. Boles
Mauro Maccarrone, Andrea Di Francesco, EPIGENETIC REGULATION OF Bernardo Dell´Osso, THE ENDOCANNABINOID SYSTEM 10.30 52 Daniela Galimberti, IN HUMAN PSYCHIATRIC A. Carlo Altamura DISORDERS and Claudio D´Addario
J.M. van Gool, GENETIC DIFFERENCES IN THE 10.45 I. Heitland, L. Groenink CB1/CNR1 GENE MODULATE FEAR 53 and J.M.P. Baas EXTINCTION IN HUMANS
A QUESTION OF RANK: John M. McPartland USING DNA BARCODES TO 11.00 54 and Geoffrey W. Guy CLASSIFY CANNABIS SATIVA AND CANNABIS INDICA
Special ICRS Speaker
OPTOGENETIC APPROACHES TO STUDYING 11.15 REWARD AND SUBSTANCE ABUSE DISORDERS
Antonello Bonci, Ph.D. National Institutes of Health
12.15 Lunch
13.15 - 15.00 Poster Session 2 P2
15.00 - OUTING
Notes:
Day 4 Wednesday, July 2nd
7.00 Breakfast
Luigia Cristino, OREXIN/ENDOCANNABINOID/ 8.15 Giovanna Morello, LEPTIN INTERACTION AFFECTS Roberta Imperatore, HYPOTHALAMIC TAU Due to 55 Fabiana Piscitelli, PHOSPHORILATION BY GLYCOGEN scheduling conflict Letizia Palomba SYNTHASE KINASE-3BETA and Vincenzo Di Marzo ACTIVATION
Oral Session 10. Focus on CB2
CHAIRS: JOSÉE GUINDON AND ANDREAS ZIMMER
Anne-Caroline Schmöle, CANNABINOID RECEPTOR 2 Ramona Göhrs, Önder DEFICIENCY ALTERS Albayram, Daniele Bano, 8.30 NEUROINFLAMMATION IN AN 56 Pierluigi Nicotera, ALZHEIMER’S DISEASE MOUSE Judith Alferink MODEL and Andreas Zimmer
SELECTIVE ACTIVATION OF Ming Gao, CB2Rs ELIMINATES VTA 8.45 Zhengxiong Xi 57 DOPAMINE NEURONAL and Jie Wu BURSTING FIRING IN RODENTS
Liting Deng, CHRONIC CANNABINOID CB2 Josée Guindon, AGONIST REVERSES PACLITAXEL Benjamin L. Cornett, 9.00 NEUROPATHY WITHOUT 58 Alexandros Makriyannis, TOLERANCE, CB1-MEDIATED Ken Mackie WITHDRAWAL OR SIDE EFFECTS and Andrea G. Hohmann
THE COMBINATION OF Josée Guindon, Liting AMITRIPTYLINE WITH FAAH OR MGL Deng, Emma Leishman, 9.15 INHIBITORS IN CHEMOTHERAPY- 59 Heather B. Bradshaw INDUCED PERIPHERAL NEUROPATHY and Andrea G. Hohmann IS CB2 MEDIATED
TAMOXIFEN IS AN ALLOSTERIC Pritesh Kumar 9.30 MODULATOR OF THE CB2 60 and Zhao-Hui Song CANNABINOID RECEPTOR
Shaojuan Zhang, Pin Shao, Ningyang Jia, Qin Tong, Xiang-qun TARGETING CB2 RECEPTOR AS A 9.45 Xie, Christina Bagia, 61 NEW PHOTOTHERAPY APPROACH Jelena M. Janjic, Ying Ding and Mingfeng Bai
10.00 Coffee Break
Oral Session 10 (cont). Focus on CB2
CHAIRS: JOSÉE GUINDON AND ANDREAS ZIMMER
Vanessa Petrucci, PEPTIDE ENDOCANNABINOIDS Andrea Chicca, Juan (PEPCANS) ARE PAMs OF CB2 10.30 62 Manuel Viveros-Paredes RECEPTORS AND INVOLVED IN THE and Jürg Gertsch INNATE IMMUNE RESPONSE
Eef L. Theunissen, Pim Heckman, Elizabeth B. de Sousa Fernandes Perna, Kim P. C. REVERSING THC-INDUCED 10.45 Kuypers, Anke Sambeth, IMPAIRMENT OF VERBAL MEMORY 63 Arjan Blokland, IN HEALTHY HUMANS Jos Prickaerts, Stefan W. Toennes and Johannes G. Ramaekers
Slava Rom, SELECTIVE STIMULATION OF Holly Dykstra, CANNABIOID TYPE 2 RECEPTORS Nancy Reichenbach, (CB2) IN MONOCYTES PREVENTS 11.00 64 Viviana Zuluaga- THEIR ENGAGEMENT OF BRAIN Ramirez ENDOTHELIUM PROTECTING BLOOD and Yuri Persidsky BRAIN BARRIER
Jenny L. Wiley, Brian F. CB2 AGONISTS: 11.15 Thomas, Hongfang Yang 65 HOW SELECTIVE ARE THEY? and Anu Mahadevan
Mario van der Stelt, Partha Mukhopadhyay, Marc Baggelaar, Zongxian Cao, Katalin PERIPHERALLY RESTRICTED, Erdelyi, Filomena Fezza, SELECTIVE CANNABINOID CB2 11.30 Bogna Ignatowska- RECEPTOR AGONIST LEI-101 66 Jankowska, Marc Ruben, PREVENTS CISPLATIN-INDUCED Resat Cinnar, George NEPHROPATHY Kunos, Aron Lichtman, Mauro Maccarrone and Pal Pacher
Jean-Michel Adam, Christian M. Apfel, Stefanie Bendels, Caterina Bissantz, Jürgen Fingerle, Ivan Formentini, Jürgen Funk, Uwe Grether, Sabine TRIAZOLOPYRIMIDINES – Grüner, Atsushi A NOVEL CLASS OF HIGHLY POTENT, 11.45 67 Kimbara, Matthias HIGHLY SELECTIVE AND IN VIVO Nettekoven, Giorgio ACTIVE CB2 AGONISTS Ottaviani, Camille Perret, Mark Rogers- Evans, Stephan Röver, Franz Schuler, Tanja Schulz-Gasch and Christoph Ullmer
12.00 Lunch
13.00 – 15.00 Poster Session 3 P3
Oral Session 11. Beyond THC: Cannabidiol and Other Components
CHAIRS: LUCIANO DE PETROCELLIS AND MICHELLE SEXTON
Attila Oláh, Lídia Ambrus, “WEED AGAINST ZIT?” – Attila G. Szöllősi, EXPLORATION OF THE MECHANISMS 15.00 68 Christos C. Zouboulis, OF THE COMPLEX ANTI-ACNE Ralf Paus ACTIONS OF CANNABIDIOL and Tamás Bíró
Jeffrey C. Raber, Sytze Elzinga, Mark E. Raber, CANNABINOID AND TERPENOID Bradley J. Douglass, 15.15 PROFILING OF CANNABIS IN 69 Cameron Miller, Aaron CALIFORNIA AND WASHINGTON Kendziorek, Justin Fischedick and Dale Gieringer
Richard C. Kevin, “SMELLS LIKE GOOD WEED”: THC David J. Allsop, LEVELS IN CANNABIS MAY BE 15.30 70 Wendy Swift PREDICTED BY MONOTERPENE and Iain S. McGregor HEADSPACE CONCENTRATIONS
Sándor Bátkai, PROTECTIVE EFFECT OF THE Partha Mukhopadhyay, PHYTOCANNABINOID BETA- 15.45 Katalin Erdélyi, 71 CARYOPHYLLENE IN LIVER Jürg Gertsch ISCHEMIA REPERFUSION INJURY and Pál Pacher
Alex Naftaly, EFFECT OF BETA-CARYOPHYLLENE Ester Fride (Z”L), 16.00 ON PHENCYCLIDINE-INDUCED 72 Jürg Gertsch BEHAVIOURAL CHANGES and Sharon Anavi-Goffer
CANNABIDIOL PROVIDES Douglas E Brenneman, PROTECTION FROM ETHANOL 16.15 Dean Petkanas AND AMMONIUM TOXICITY 73 and William A. Kinney IN A HIPPOCAMPAL MODEL OF HEPATIC ENCEPHALOPATHY
Andrea Chicca, Diego
Caprioglio, Alberto NATURAL PRODUCT-DERIVED Minassi, Vanessa CANNABMIMETICS AS SOURCE OF 16.30 Petrucci, Salome Gachet, 74 POLYPHARMACOLOGY IN THE Giovanni Appendino, ENDOCANNABINOID SYSTEM Orazio Taglialatela-
Scafati and Jurg Gertsch
Alline Campos, CANNABIDIOL REPEATED Aline Miranda, Fatima TREATMENT INCREASES SURVIVAL 16.45 Brant, Fabiana Machado, AND PROMOTES RESCUE OF 75 Francisco Guimaraes COGNITIVE FUNCTION IN A MURINE and Antonio Teixeira MODEL OF CEREBRAL MALARIA
Maria Ceprian, Maria CANNABIDIOL PROMOTES Ruth Pazos, Federica OLIGODENDROCYTE SURVIVAL 17.00 Penna, Laura Jimenez- 76 AFTER HYPOXIA-ISCHEMIA IN Sanchez, Martin Santos NEWBORN RATS and Jose Martinez
Nadia Solowij, Erika van Hell, Samantha Broyd, Lisa-marie Greenwood, EFFECTS OF CBD ALONE AND IN 17.15 Jelena Novakovic, COMBINATION WITH THC ON 77 Camilla Beale, COGNITIVE PERFORMANCE Dave Martelozzo, Arno Hazekamp and Rodney Croft
Laura Jimenez-Sanchez, Ruth Pazos, ROLE OF 5HT1A RECEPTORS ON Hector Lafuente, Lorena THE NEUROPROTECTIVE AND Barata, Maria Ceprian, 17.30 NEUROBEHAVIORAL EFFECTS OF 78 Martin Santos, CANNABIDIOL IN HYPOXIC- Francisco Jose Alvarez ISCHEMIC NEWBORN PIGS and Jose Martinez- Orgado
THE ANXIOLYTIC-LIKE EFFECT OF CANNABIDIOL ADMINISTRATION IN Manoela V. Fogaça, CHRONICALLY STRESSED MICE IS 17.45 Alline C. Campos and MEDIATED BY THE 79 Francisco S. Guimarães ENDOCANNABINOID SYSTEM: INVOLVEMENT OF NEUROGENESIS AND AUTOPHAGY
RESULTS FROM AUDITING MEDICAL 18.00 Jahan P. Marcu CANNABIS FACILITIES IN THE 80 UNITED STATES IN 2014
18.15 ICRS BUSINESS MEETING
20.00 ICRS BANQUET
POSTER SESSION 1: TOPICS A - E DAY 1, SUNDAY, JUNE 29th: 13:00 - 15:00
TOPIC A. Cannabinoids and Pathophysiology
Michiel Balvers, Pim Koelink, Aletta Kraneveld, THE N-3 N-ACYLETHANOLAMIDE DHEA Mieke Poland, IMPROVES MANIFESTATIONS OF P1-1 Jocelijn Meijerink EXPERIMENTAL MURINE COLITIS and Renger Witkamp
THE ENDOCANNABINOID SYSTEM IS Valerio Chiurchiù, Emanuela A NOVEL MODULATOR OF HUMAN Talamonti, Alessandro Leuti P1-2 MACROPHAGE PLASTICITY AND and Mauro Maccarrone POLARIZATION
Caroline Turcotte, Simona Zarini, Stéphanie Jean, Cyril PROSTAGLANDIN D2-GLYCEROL Martin, Véronique Provost, AND E2-GLYCEROL INHIBIT HUMAN P1-3 Adam Uzieblo, Robert C NEUTROPHIL FUNCTIONS Murphy and Nicolas Flamand
EVIDENCE THAT THE NOVEL Mark Jones, Marie Smith, ENDOCANNABINOID VIRODHAMINE Susan Anderson INCREASES OSTEOBLAST P1-4 and Saoirse E. O’Sullivan PROLIFERATION: A ROLE FOR CB2 AND GPR55
THE EFFECT OF CANNABINOIDS ON Valerie CM Shang, David A HUMAN BRONCHIAL EPITHELIAL CELL P1-5 Kendall and Richard E Roberts PERMEABILITY
Ku-Lung Hsu, Katsunori Tsuboi, Alexander Adibekian, Holly Pugh, Kim Masuda, INACTIVATION OF DIACYLGLYCEROL Sudeshna Ghosh, Manuel P1-6 LIPASE IN INFLAMMATORY DISEASE Sanchez-Alavez, Aron Lichtman, Bruno Conti and Benjamin F. Cravatt
DOCOSAHEXAENOYL-SEROTONIN Jocelijn Meijerink, (DHA-5-HT), AN INTESTINAL Zheng Wang, Mieke Poland, CONJUGATE OF SEROTONIN P1-7 Jean-Paul ten Klooster AND DHA EXHIBITS ANTI- and Renger Witkamp INFLAMMATORY PROPERTIES
Michael M. McDonald, THE DEVELOPMENT OF A Amos Matsiko, Adolfo López CANNABINOID-CONTAINING Noriega, Hugo D. Kieran, COLLAGEN-GAG SCAFFOLD FOR P1-8 Aoife Gowran, Kevin J. USE IN ORTHOPAEDIC TISSUE Mulhall, Fergal J. O’Brien ENGINEERING STRATEGIES and Veronica A. Campbell
Valerio Chiurchiù, Emanuela ENDOCANNABINOIDS DIFFERENTIALLY Talamonti, Mirko Lanuti MODULATE NLRP3 INFLAMMASOME P1-9 Tiziana Bisogno ACTIVATION IN PRIMARY HUMAN and Mauro Maccarrone MACROPHAGES
Michel Laviolette, Marie- METABOLISM OF EXOGENOUS Chantal Larose, Caroline ARACHIDONOYL-ETHANOLAMIDE Turcotte, Véronique Provost, P1-10 AND 2-ARACHIDONOYL-GLYCEROL Cyril Martin, Catherine Laprise BY HUMAN EOSINOPHILS and Nicolas Flamand
INFLUENCE OF THE DOPAMINE Amina M. Bagher, Robert B. RECEPTOR TYPE 2 (D2) ANTAGONIST Laprairie, Melanie E.M. Kelly P1-11 ON THE CANNABINOID RECEPTOR and Eileen M. Denovan-Wright TYPE 1 (CB1) FUNCTION
Attila Oláh, Nóra Czakó, EFFECTS OF CONTROLLED, TRANSIENT Levente Molnár, Stefania HYPEROXIA ON THE SERUM LEVELS OF Petrosino, Teresa Aveta, P1-12 DIFFERENT ENDOCANNABINOIDS – Vincenzo Di Marzo, Béla A HUMAN PILOT STUDY Fülesdi and Tamás Bíró
THE PERIPHERALLY-RESTRICTED Herbert H. Seltzman, Yatendra CANNABINOID RECEPTOR AGONIST P1-13 Mulpuri and Igor Spigelman PRNMI ALLEVIATES CISPLATIN INDUCED PERIPHERAL NEUROPATHY
OLEOYLETHANOLAMIDE (OEA) AND Mustafa Karwad, PALMITOYLETHANOLAMIDE (PEA) Karen L. Wright, Michael MODULATE INTESTINAL P1-14 Larvin, Jonathan Lund PERMEABILITY IN AN IN VITRO and Saoirse E. O’Sullivan ISCHAEMIA/REPERFUSION MODEL
Ya Wang, Pierluigi Plastina, N-ACYLDOPAMINES DERIVED FROM Michiel Balvers, Mieke Poland, POLYUNSATURATED OMEGA-3 FATTY Bartolo Gabriele, Jean-Paul P1-15 ACIDS EXERT ANTI-INFLAMMATORY Vincken, Renger Witkamp EFFECTS IN MOUSE MACROPHAGES and Jocelijn Meijerink
RATIONALE FOR TARGETING THE Natalia Malek, Katarzyna ENDOCANNABINOID SYSTEM Popiolek-Barczyk, Joanna TO MANAGE NEUROINFLAMMATION P1-16 Mika, Barbara Przewlocka IN LPS-ACTIVATED PRIMARY and Katarzyna Starowicz MICROGLIAL CULTURES
Haley A. Vecchiarelli, Catherine M. Keenan, J. Megan COLITIS ALTERS CENTRAL Gray, Mohammad Bashashati, P1-17 ENDOCANNABINOID CONTENT Keith A. Sharkey and Matthew N. Hill
Ulrike Taschler, Martina MONOGLYCERIDE LIPASE DEFICIENCY Schweiger, Martin A. Storr, CAUSES INTESTINAL CANNABINOID P1-18 Rudolf Schicho RECEPTOR DESENSITIZATION and Robert Zimmermann
Elizabeth A. Cairns, Michele L. Archibald, Alex J. MODIFYING CB1 RECEPTOR Straiker, Pushkar M. Kulkarni, SIGNALLING TO REDUCE P1-19 Ganesh A.Thakur, IOP IN A MOUSE MODEL OF William H. Badridge OCULAR HYPERTENSION and Melanie E.M. Kelly
TOPIC B. Pain and TRPs
DIRECT ADMINISTRATION OF N- Bright N Okine, Manish K. PALMITOYLETHANOLAMIDE INTO THE Madasu, Fiona McGowan, RAT MEDIAL PREFRONTAL CORTEX P1-20 Brendan Harhen, Michelle REDUCES FORMALIN-EVOKED Roche and David P. Finn NOCICEPTIVE BEHAVIOUR VIA A CB1 RECEPTOR-MEDIATED MECHANISM
Mireille Alhouayek, Baptiste COMPARISON OF THE EFFECTS Buisseret, Owein Guillemot- OF INHIBITION OF ABHD6 P1-21 Legris and Giulio G. Muccioli AND MAGL ON INFLAMMATION
Samira Khakpour, Kevin INVESTIGATION OF THE ROLE Wilhelmsen, Alphonso Tran OF THE TRPV1 CHANNEL IN P1-22 and Judith Hellman ENDOTHELIAL INFLAMMATION
Martin Kaczocha, Syed Azim, ENDOCANNABINOID LEVELS James Nicholson, AND FUNCTIONAL DISABILITY Mario J. Rebecchi, STATUS IN PATIENTS WITH P1-23 William Galbavy, Tian Feng PAINFUL OSTEOARTHRITIS and Helene Benveniste
William Notcutt, Cheryl Phillips, Phillipe A RETROSPECTIVE DESCRIPTION Lacoux, Adrian Shanks, OF THE USE OF NABILONE P1-24 Viji Vijayakulasingam IN UK CLINICAL PRACTICE and Laura Baldock
Pierluigi Plastina, HYDROXYTYROSYL OLEATE, AN ESTER Mieke Poland, Jocelijn ANALOGUE OF OLEOYLDOPAMINE P1-25 Meijerink, Bartolo Gabriele (OLDA), SHOWS ANTI-INFLAMMATORY and Renger Witkamp PROPERTIES IN VITRO
Molly S. Crowe, ATTENUATING NEUROPATHIC PAIN Emma Leishman, Ramesh THROUGH DUAL INHIBITION OF Gujjar, Anu Mahadevan, P1-26 CYCLOOXYGENASE AND Matthew Banks, Heather MONOACYLGLYCEROL LIPASE Bradshaw and Steven G. Kinsey
ANANDAMIDE MEDIATES Iryna Khasabova, Cutler THE ANTIHYPERALGESIC EFFECT Lewandowski, Xu Yao, Justin OF 2AG IN A MURINE MODEL OF P1-27 Paz, Natalya Burlakova, Donald CHEMOTHERAPY-INDUCED Simone and Virginia Seybold NEUROPATHY
THE MONOACYGLYCEROL LIPASE Sara R. Nass INHIBITOR JZL184 ATTENUATES P1-28 and Steven G. Kinsey HYPERALGESIA INDUCED BY COLLAGEN-INDUCED ARTHRITIS
LONG-TERM SOCIAL REJECTION Peggy Schneider, Laura DURING ADOLESCENCE ALTERS Bindila, Beat Lutz, Rainer PAIN PERCEPTION AND AFFECTS P1-29 Spanagel and Miriam Schneider THE ENDOCANNABINOID SYSTEM IN ADULT FEMALE RATS
Luciano De Petrocellis, “ENTOURAGE” EFFECTS OF Stefania Petrosino, Aniello PALMITOYLETHANOLAMIDE: Schiano Moriello, Santiago ENHANCEMENT OF 2-AG ACTION P1-30 Cerrato, Mariella Fusco, AT TRPV1 CHANNELS AND OF 2-AG Anna Puigdemont LEVELS IN VITRO AND IN VIVO and Vincenzo Di Marzo
ANTI-INFLAMMATORY EFFECTS OF THE CB1/CB2 AGONIST WIN55212,2 Torsten Lowin, ARE DEPENDENT ON TRPV1, TRPA1 Angelika Gräber P1-31 AND AMPK IN RHEUMATOID ARTHRITIS and Rainer H. Straub AND OSTEOARTHRITIS SYNOVIAL FIBROBLASTS
DIFFERENTIAL EFFECTS OF PHARMACOLOGICAL MODULATION Manish K. Madasu, OF TRPV1 IN THE LATERAL Bright N. Okine, Weredeselam PERIAQUEDUCTAL GREY ON P1-32 M. Olango, Michelle Roche FORMALIN-EVOKED NOCICEPTIVE and David P. Finn BEHAVIOUR IN SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
Carmen La Porta, Simona ROLE OF CB1 AND CB2 CANNABINOID Andreea Bura, Antoni Pastor, RECEPTORS IN THE EMOTIONAL AND Rafael de la Torre, Francisco P1-33 COGNITIVE ALTERATIONS ASSOCIATED Navarrete, Jorge Manzanares WITH OSTEOARTHRITIS PAIN and Rafael Maldonado
TOPIC C. Developmental
AGE OF EXPOSURE AFFECTS BEHAVIORAL RESPONSE TO Lindsay Silva, Rita Black DELTA-9-TETRAHYDROCANNABINOL P1-34 and Diana Dow-Edwards DURING THE PERI-PUBERTAL PERIOD IN THE RAT
Justine Renard, Michael LONG-TERM EFFECTS OF ADOLESCENT Loureiro, Walter J. Rushlow THC EXPOSURE ON ADULTHOOD P1-35 and Steven R. Laviolette PSYCHOPATHOLOGY
Marcoita T. Gilbert, A MOUSE MODEL SHOWS SYNTHETIC Scott E. Parnell, Eric W. Fish, CANNABINOID TERATOGENICITY P1-36 Lorinda K. Baker AND PROMISE FOR PRENATAL DRUG and Kathleen K. Sulik CO-EXPOSURE RESEARCH
MODULATORY INFLUENCE OF THE DEVELOPING ENDOCANNABINOID Anja Goepfrich SYSTEM ON COGNITIVE ABILITIES P1-37 and Miriam Schneider DURING ADOLESCENT BRAIN DEVELOPMENT IN RATS
TOPIC D. Cannabinoids and Cancer
LYPLA2 IS A MAJOR PROSTAGLANDIN Joseph D. Manna GLYCEROL ESTER HYDROLASE IN P1-38 and Lawrence J. Marnett HUMAN CANCER CELLS
Elisa Bisicchia, Filomena Fezza, Emanuela Talamonti, Mirko Lanuti, ROLE OF THE ENDOCANNABINOID P1-39 Valerio Chiurchiù, Sergio Oddi, SYSTEM IN AUTOPHAGY Marco Molinari and Mauro Maccarrone
Tiziana Bisogno, Alberto Rainer, Luca Businaro, ANALYSIS OF ENDOCANNABINOID Emanuela Talamonti, Marcella SYSTEM IN A 3D “CELL-ON-CHIP” P1-40 Trombetta, Daniele Santini MODEL OF HUMAN TUMORS and Mauro Maccarrone
CYCLOOXYGENASE-2-DEPENDENT Seok-Woo Park GROWTH INHIBITION OF P1-41 and Myung-Whun Sung ARACHIDONOYL ETHANOLAMIDE ON LARYNGEAL CANCER CELLS
DEVELOPMENT OF A Δ9-THC PRODRUG TRANSDERMAL DELIVERY SYSTEM FOR Stan L. Banks, Miro Golinski, PREVENTION OF ACUTE AND DELAYED Jeff Howard, Dana Hammell NAUSEA AND VOMITING ASSOCIATED P1-42 and Audra L. Stinchcomb WITH INITIAL AND REPEAT COURSES OF EMETOGENIC CANCER CHEMOTHERAPY
Maria Chiara Proto, Antonio Christian Pagano Zottola, Donatella Fiore, Simona ENDOCANNABINOID-INDUCED Pisanti, Paola Picardi, Elena GROWTH INHIBITION OF HUMAN P1-43 Ciaglia, Anna Maria Malfitano, COLON CANCER: INVOLVEMENT OF Alba D’Alessandro, Chiara WNT/β-CATENIN PATHWAY Laezza, Maurizio Bifulco and Patrizia Gazzerro
A REVIEW OF THE USE OF HERBAL N. Rielle Capler CANNABIS AND CANNABIS EXTRACTS P1-44 and Lynda G. Balneaves FOR THE TREATMENT OF CANCER AND CANCER-RELATED SYMPTOMS
AN IN VITRO EVALUATION Thomas D. M. Hill, OF COMBINATIONS OF Colin G. Stott PHYTOCANNABINOIDS IN PANCREATIC, P1-45 and Marnie Duncan GASTRIC, RENAL, BLADDER AND LIVER CANCER CELL LINES
EFFECT OF N-ARACHIDONOYH Ghayth M. Abdulrazzaq, GLYCIN (NAGly) AND Sue Chan ∆9 -TETRAHYDROCANNABINOL P1-46 and Stephen PH Alexander (∆9THC) ON ERK1/2 PHOSPHORYLATION IN NATIVE HEK293 CELLS
TOPIC E. Cannabinoid Receptors and Signaling
Elham Khajehali, ALLOSTERIC MODULATION AND Daniel T. Malone BIASED SIGNALLING AT CB1 P1-47 and Katie Leach CANNABINOID RECEPTORS
Orla Haugh, PROFILING THE ACTIVITY Cullen McCulloch, OF GPR55 ANTAGONISTS P1-48 June Penman AGAINST RECOMBINANT and Andrew J. Irving AND ENDOGENOUS GPR55
ROLE OF INTRACELLULAR LOOPS IN Jagjeet Mnpotra, Diane Lynch, THE HYDRATION OF GDP: RESULTS Alan Grossfield, Nicholas FROM MOLECULAR DYNAMICS P1-49 Leioatts, Michael Pitman SIMULATIONS OF THE 2-AG and Patricia Reggio ACTIVATED CANNABINOID RECEPTOR SUBTYPE 2 / Gi PROTEIN COMPLEX
CB1 RECEPTOR INTRACELLULAR LOOP Khalil Eldeeb, Sandra Leone- 4 MUTATION MODULATES G PROTEIN Kabler, Lawrence C. Blume P1-50 ACTIVATION AND CAMP PRODUCTION and Allyn C. Howlett IN HUMAN NEUROBLASTOMA CELLS
POSTER SESSION 2: TOPICS E - H DAY 3, TUESDAY, July 1st: 13:15 - 15:00
TOPIC E (cont.) Cannabinoid Receptors and Signaling
Matthew W. Buczynski, Melissa A. Herman, Ku-Lung CHRONIC NICOTINE EXPOSURE Hsu, Luis A. Natividad, DIMINISHES INHIBITORY CONTROL Cristina Irimia, Ilham Y. Polis, OF VTA DA NEURONS THROUGH Holly Pugh, Jae Won Chang, ENHANCED DIACYLGLYCEROL P2-1 Micah J. Niphakis, LIPASE-MEDIATED Benjamin F. Cravatt, 2-ARACHIDONOYLGLYCEROL Marisa Roberto SIGNALING and Loren H. Parsons
A GPR119-BASED SIGNALING SYSTEM Alex Straiker, Sherry Hu, IN THE MURINE EYE REGULATES Karl Spork, Emma Leishmann P2-2 INTRAOCULAR PRESSURE IN A and Heather Bradshaw SEX-DEPENDENT MANNER
CANNABINOID CB1 RECEPTOR- Richard S Priestley, MEDIATED ERK1/2 RESPONSES - Sarah A. Nickolls, EVIDENCE OF G PROTEIN- P2-3 Stephen P.H. Alexander I/O INDEPENDENT SIGNALLING and David A Kendall AND AGONIST BIAS
Toru Uyama, Manami Inoue, Yoko Okamoto, Naoki PEROXISOMAL DYSFUNCTION BY Shinohara, Tatsuya Tai1, PLA/AT FAMILY PROTEINS IS NOT Masahiro Watanabe, Iffat Ara P2-4 RELATED TO THEIR NAPE-FORMING Sonia Rahman, Kazuhito N-ACYLTRANSFERASE ACTIVITY Tsuboi, Tomohito Inoue, Akira Tokumura and Natsuo Ueda
Jayendra Z. Patel, Stephen Ahenkorah, Yahaya Adams, Susanna M. Saario, Teija LORATADINE ANALOGUES P2-5 Parkkari, Juha R. Savinainen, AS MAGL INHIBITORS Jarmo T. Laitinen and Tapio Nevalainen
Dow P. Hurst, Diane L. Lynch, MODELING THE ORG27569 INDUCED Derek M. Shore, CB1/BETA-ARRESTIN 1 COMPLEX THAT P2-6 Michael C. Pitman ACTIVATES AN ARRESTIN BIASED and Patricia H. Reggio PATHWAY
PHARMACOLOGICAL William A. Devane CHARACTERISATION OF A BINDING P2-7 and David P. Finn SITE FOR [3H]LEELAMINE
Abhijit R. Kulkarni, Pushkar M. Kulkarni, Anisha Korde, DESIGN, SYNTHESIS AND Nicolai Zvonok, BIOCHEMICAL EVALUATION OF NOVEL Maria Grazia Cascio, ELECTROPHILIC AND PHOTOAFFINITY P2-8 Alexandros Makriyannis, COVALENT PROBES TO MAP THE CB1 Roger G. Pertwee RECEPTOR ALLOSTERIC SITE(S) and Ganesh A. Thakur
REVIEW OF EVIDENCE FOR Saoirse O’Sullivan, CANNABINOID RECEPTORS AND Sara Goodacre ENDOCANNABINOID SIGNALLING IN P2-9 and Jonathan Yee INVERTEBRATES WITH A SPECIFIC FOCUS ON ARACHNIDS
Carmen Rodríguez-Cueto, ANALYSIS OF THE ENDOCANNABINOID Mariluz Hernández-Gálvez, SIGNALING SYSTEM IN BRAIN Cecilia J. Hillard, Patricia P2-10 STRUCTURES OF SCA-3 Maciel, Javier Fernández-Ruiz TRANSGENIC MICE and María Gómez-Ruiz
THE N-ACYL AMINO ACIDS, June Penman, N-ARACHIDONOYL-L-SERINE Emanuel Ferreira Lopes P2-11 AND N-ARACHIDONOYL GLYCINE, and Andrew J. Irving ACTIVATE GPR55
SIMULTANEOUS DETERMINATION OF ENDOCANNABINOID AND Christoph Porazik, PROSTAGLANDIN BIOMARKERS AND Anke Witting P2-12 OF MONOACYLGLYCEROL LIPASE and Boris Ferger INHIBITOR EXPOSURE USING A NEW AND FAST LC-MS/MS-METHOD
EFFECTS OF NOVEL SEMI-SYNTHETIC Marcus R. Goetz, Oskar Koch, CANNABINOIDS ON CB1 AND CB2 Eduardo Munoz E P2-13 RECEPTORS THROUGH BINDING AND and Bernd L. Fiebich SIGNALLING
REVIEW OF THE EVIDENCE FOR Jonathan Yee, CANNABINOID RECEPTORS IN Saoirse O’Sullivan P2-14 INVERTEBRATES WITH A SPECIFIC and Sara Goodacre FOCUS ON ARACHNIDS
TOPIC F. Cannabis Use and Abuse Issues
CANNABIS OIL – CHEMICAL Luigi L. Romano EVALUATION OF AN UPCOMING P2-15 and Arno Hazekamp CANNABIS-BASED MEDICINE
Jennifer Johnston, Nicholas Lintzeris, David J. LITHIUM CARBONATE IN THE Allsop, Anastasia Suraev, MANAGEMENT OF CANNABIS Jessica Booth, Dean S. Carson, WITHDRAWAL: A RANDOMIZED P2-16 David Helliwell, PLACEBO-CONTROLLED TRIAL Adam Winstock IN AN INPATIENT SETTING and Iain S. McGregor
CANNABIS USE AND PERPETRATION Kim Crosby OF INTIMATE PARTNER VIOLENCE: P2-17 and Zach Walsh THE MODERATING ROLE OF PROBLEMATIC ALCOHOL USE
Brian F. Thomas, WHAT GOES UP IN SMOKE: Richard C. Daw, Poonam G. THE IDENTIFICATION AND Pande, Anderson O. Cox, PHARMACOLOGICAL Alex L. Kovach, Kenneth H. CHARACTERIZATION OF P2-18 Davis, Jenny L. Wiley, SYNTHETIC CANNABINOID Kenneth S. Rehder PYROLYSIS PRODUCTS FORMED and Megan Grabenauer DURING SMOKING
Sonia Aroni, Claudia Sagheddu, NEURONAL CIRCUITS UNDERLYING Marco Pistis P2-19 CANNABINOID WITHDRAWAL and Anna Lisa Muntoni
Kiri L.Wills, Kiran Vemuri, DELIVERY OF THE CB1 ANTAGONIST, Alana Kalmar, AM251, BILATERALLY TO THE CENTRAL Cheryl L. Limebeer, P2-20 NUCLEUS OF THE AMYGDALA AND ITS Alexandros Makriyannis EFFECTS ON MORPHINE WITHDRAWAL and Linda A. Parker
BDNF INTERACTS WITH Yong Liu, Ying Hu, ENDOCANNABINOIDS TO REGULATE Peng Zhong COCAINE-INDUCED SYNAPTIC P2-21 and Qing-song Liu PLASTICITY IN MOUSE MIDBRAIN DOPAMINE NEURONS
INTEGRAL FRAMES: Regina Nelson INTERDISCIPLINARY TOOLS P2-22 SUPPORTING CANNABIS RESEARCH
C57BL6/J DEVELOP TOLERANCE TO Travis Grim, CP55,940 IN INTRACRANIAL SELF- Jason Weibelhaus, Steve Negus P2-23 STIMULATION OF THE MEDIAL and Aron Lichtman FOREBRAIN BUNDLE
CANNABINOID CB1 RECEPTOR TRANSMISSION IN THE BASOLATERAL AMYGDALA BI-DIRECTIONALLY Tasha Ahmad CONTROLS THE MOTIVATIONAL P2-24 and Steven R. Laviolette PROPERTIES OF OPIATES VIA FUNCTIONAL EXCITATORY INPUTS TO THE NUCLEUS ACCUMBENS SHELL
Kristin M. Gabella, RIMONABANT-PRECIPITATED ∆9-THC Margaret S. Jones, WITHDRAWAL ALTERS MARBLE Molly S. Crowe, P2-25 BURYING AND STRUGGLING Sara R. Nass BEHAVIORS IN MICE and Steven G. Kinsey
FATTY ACID AMIDE HYDROLASE Lena Bergström, Shima (FAAH) ACTIVITY IN DIFFERENT RAT Momeni, Hanna Eriksson- P2-26 BRAIN REGIONS AFTER TWO WEEKS Röhnisch and Erika Roman TREATMENT WITH ETHANOL
TOPIC G. Metabolism
Tania Muller, Stephanie Troy- ACTIVATION OF ADIPOSE TISSUE Fioramonti, Laurent Demizieux, CANNABINOID RECEPTORS 1 Joseph Gresti, Maria Bouam, (CB1R) ALTERS ANTILIPOLYTIC P2-27 BrunoVergès ACTION OF INSULIN AND and Pascal Degrace INCREASES LIPOLYSIS IN MICE
PERIPHERAL ENDOCANNABINOID Stephanie Troy-Fioramonti, SYSTEM ACTIVATION INHIBITS Laurent Demizieux, INTESTINAL GLUCOSE ABSORPTION P2-28 Joseph Gresti, Bruno Vergès AND IMPROVES POSTPRANDIAL and Pascal Degrace GLYCEMIA IN LEAN AND OBESE MICE
Maria Scherma, PHARMACOLOGICAL MODULATION Valentina Satta, Roberto Collu, OF THE ENDOCANNABINOID P2-29 Liana Fattore, Paola Fadda SYSTEM IN A RODENT MODEL and Walter Fratta OF “ACTIVITY-BASED ANOREXIA”
SYNTHESIS AND CHARACTERIZATION Oliver Linsell, Khaled Greish OF A NANOMICELLE CANNABINOID P2-30 and John C. Ashton FORMULATION
INHIBITION OF ENDOCANNABINOID Jessica Karlsson METABOLISM BY THE METABOLITES P2-31 and Christopher J. Fowler OF IBUPROFEN AND FLURBIPROFEN
Sandra Gouveia-Figueira, DIETARY EFFECTS ON CIRCULATING Jana Späth, Angela Zivkovic P2-32 OXYLIPINS AND ENDOCANNABINOIDS and Malin L. Nording
Giovanna Morello, Roberta OREXIN-A ENHANCES 2-AG Imperatore, Fabiana Piscitelli, BIOSYNTHESIS VIA CB1/OX-1R Daniela Sarnataro, Letizia HETEROMERS IN THE NEURONS P2-33 Palomba, Luciano De OF THE MOUSE HYPOTHALAMIC Petrocellis, Luigia Cristino ARCUATE NUCLEUS and Vincenzo Di Marzo
Julius T. Dongdem, INHIBITION OF RAT LIVER FAAH Simon P. Dawson ACTIVITY USING THREE DIFFERENT P2-34 and Stephen P. H. Alexander FATTY ACID AMIDES AS SUBSTRATES
Antoni Pastor, Magí Farré, EX-VIVO ENZYMATIC GENERATION Montserrat Fitó, OF 2-AG AND OTHER P2-35 Fernando Fernandez-Aranda 2-MONOACYLGLYCEROLS IN PLASMA and Rafael de la Torre
Caroline Turcotte, Cyril Martin, EXPRESSION OF ENZYMES INVOLVED Véronique Provost IN ENDOCANNABINOID METABOLISM P2-36 and Nicolas Flamand BY HUMAN LEUKOCYTES
TOPIC H. CNS and Psychiatric Issues
Tamar Harpaz, Merav Hajbi, Efrat Sasson, SR141716A-INDUCED HYPERACTIVITY Tamar Blumenfeld-Katzir, P2-37 IS NOT REVERSED BY RITALIN Iain Greig, Ester Fride (Z”L) and Sharon Anavi-Goffer
Krisztina Monory, CANNABINOID CB1 RECEPTOR Martin Polack, Anita Remus, CALIBRATES EXCITATORY P2-38 Beat Lutz SYNAPTIC BALANCE IN and Martin Korte THE MOUSE HIPPOCAMPUS
THE THERAPEUTIC EFFICACY Robert B. Laprairie, OF CANNABINOID RECEPTOR TYPE 1 Amina M. Bagher, Melanie (CB1) LIGANDS IN HUNTINGTON’S P2-39 E.M. Kelly, Denis J. Dupré DISEASE DEPENDS ON THEIR and Eileen M. Denovan-Wright FUNCTIONAL SELECTIVITY
EVALUATION OF PHYTOCANNABINOID Sara Valdeolivas, COMBINATIONS AS A DISEASE- Onintza Sagredo MODIFYING THERAPY IN R6/2 MICE, P2-40 and Javier Fernández-Ruiz A GENETIC MODEL OF HUNTINGTON’S DISEASE
Fabricio A. Moreira, Luciano R. Vilela, Pedro H. INHIBITION OF FATTY ACID AMIDE Gobira, Daniel C. Medeiros, HYDROLASE (FAAH) PREVENTS P2-41 Fabiola M. Ribeiro, COCAINE-INDUCED SEIZURE AND Antonio C. de Oliveira NEUROTOXICITY and Marcio F. Moraes
Sabrina F. Lisboa, Andréia L. REPEATED TREATMENT WITH THE da Silva, Laura H.A. Camargo, FAAH INHIBITOR URB597 ATTENUATES P2-42 Leonardo B.M. Resstel LONG-LASTING CONSEQUENCES OF and Francisco S. Guimarães PREDATOR EXPOSURE IN MICE
Christine A. Rabinak, Shoko CANNABINOID EFFECTS ON Mori, Maryssa Lyons, Mike PREFRONTAL ACTIVATION DURING P2-43 Angstadt and K. Luan Phan REGULATION OF NEGATIVE AFFECT
DISSOCIATING THE PSYCHOACTIVE Jordan Zunder, EFFECTS OF DISTINCT MARIJUANA Michael Loureiro P2-44 COMPOUNDS IN THE and Steven R. Laviolette MESOCORTICOLIMBIC CIRCUITRY
Antonia Manduca, Maria DUAL FATTY ACID AMIDE HYDROLASE Morena, Michela Servadio, AND MONOACYLGLYCEROL LIPASE Lidia Montebello, Riccardo P2-45 INHIBITION AFFECTS SOCIO- Dore, Patrizia Campolongo EMOTIONAL RESPONSES IN RATS and Viviana Trezza
Noemi Pasquarelli, Michael THERAPEUTIC EFFECT OF THE Engelskirchen, Johannes MONOACYLGLYCEROL LIPASE Hanselmann, Christoph INHIBITOR KML29 IN THE SOD1G93A P2-46 Porazik, Diana Wiesner, MOUSE MODEL OF AMYOTROPHIC Patrick Weydt, Meliha Karsak, LATERAL SCLEROSIS Boris Ferger and Anke Witting
CANNABIDIOL AND ULTRA-LOW DOSES OF TETRAHYDROCANNABINOL Miriam Fishbein-Kaminietsky, PROVIDE TWO DIFFERENT Mikhal Gafni P2-47 MODES OF NEUROPROTECTION and Yosef Sarne AGAINST INFLAMMATION- INDUCED COGNITIVE DAMAGE
Natalia I. Brzozowska, REPEATED LOW-DOSE Δ9-THC Aurelie A. Boucher, PROMOTES LONG-TERM REDUCTIONS Kong M. Li, Alex Wong, IN THE ACTUE NEUROBEHAVIOURAL P2-48 Xiao Suo Wang EFFECTS OF THE ATYPICAL and Jonathon C. Arnold ANTIPSYCHOTIC RISPERIDONE
Floor Remmers , Martina GLUTAMATERGIC AND Hamann, Hector Romo-Parra, GABAERGIC COMPONENTS OF THE Sabine Ruehle, ENDOCANNABINOID SYSTEM AND P2-49 Giovanni Marsicano, THEIR INVOLVEMENT IN PROCESSING Hans-Christian Pape OF INNATE AND LEARNED FEAR and Beat Lutz
ENDOCANNABINOID AUGMENTATION Joyonna C. Gamble-George, THROUGH SUBSTRATE-SELECTIVE Daniel J. Hermanson, COX-2 INHIBITION: BEHAVIORAL P2-50 Lawrence J. Marnett EFFECTS IN AN ANIMAL MODEL OF and Sachin Patel STRESS-INDUCED ANXIETY
POSTER SESSION 3: TOPICS H - K DAY 4, Wednesday, July 2nd: 13:00 - 15:00
TOPIC H (cont.) CNS and Psychiatric Issues
CHRONIC ADOLESCENT CANNABINOID Silvain S. Dang, EXPOSURE CAUSES LONG-TERM Tiffany T.Y. Lee P3-1 CHANGES IN ADULT SEXUAL and Boris B. Gorzalka BEHAVIOUR IN MALE RATS
ELEVATION OF KYNURENIC ACID Claudia Sagheddu, LEVELS SUPPRESSES DELTA9- Salvatore Lecca, TETRAHYDROCANNABINOL-INDUCED Antonio Luchicchi, EXCITATION OF MESOLIMBIC P3-2 Steven Goldberg DOPAMINE AND PREFRONTAL CORTEX and Marco Pistis PYRAMIDAL NEURONS
PROTEIN KINASE-C GAMMA Maria Gomis-González, INVOLVEMENT IN THE NEGATIVE Arnau Busquets-Garcia, EFFECTS PRODUCED BY DELTA9- P3-3 Emma Puighermanal, Rafael TETRAHYDROCANNABINOL ON Maldonado and Andrés Ozaita MEMORY CONSOLIDATION
AN INVESTIGATION OF PANX 1 Steven G. Fagan MEMBRANE CHANNELS IN and Veronica A. Campbell P3-4 CANNABINOID MEDIATED
NEUROPROTECTION
Filomena Fezza, Maria Cristina DISTINCT MODULATION OF Marrone, Riccardo Avvisati, THE ENDOCANNABINOID SYSTEM Monia Di Tommaso, Mirko UPON KAINIC ACID-INDUCED P3-5 Lanuti, Cinzia Rapino, Nicola IN VIVO SEIZURES AND IN VITRO B. Mercuri, Silvia Marinelli EPILEPTIFORM BURSTING and Mauro Maccarrone
LONG-TERM EFFECTS OF ADOLESCENT Tiffany T.-Y. Lee, CB1 RECEPTOR ANTAGONISM: Matthew N. Hill RELEVANCE TO STRESS RESPONSIVITY P3-6 and Boris B. Gorzalka AND EMOTIONAL BEHAVIOUR IN ADULT MALE RATS
Vincenzo Micale, Vladimír EARLY MODIFICATION OF THE Pekařík, Fabio Iannotti, ENDOCANNABINOID SYSTEM Jana Kucerova, Teresa Aveta, ACCOMPANIES THE LATE Katarina Tabiová, P3-7 BEHAVIORAL PHENOTYPE Filippo Drago, OF A RODENT DEVELOPMENTAL Vincenzo Di Marzo MODEL OF SCHIZOPHRENIA and Alexandra Sulcova
Anastasia Piyanova, Onder Albayram, Carlo LOSS OF CB1 RECEPTORS LEADS Alberto Rossi, Hany Farwanah, TO DECREASED CATHEPSIN D LEVELS Kerstin Michel, P3-8 AND ACCELERATED LIPOFUSCIN Pierluigi Nicotera, ACCUMULATION IN THE HIPPOCAMPUS Konrad Sandhoff and Andras Bilkei-Gorzo
Mikael Alexander Kowal, Arno Hazekamp, Lorenza Serena Colzato, THE EFFECT OF CANNABIS ON Jeffrey Durieux, Meriem DIVERGENT AND CONVERGENT P3-9 Manai, Nic van der Wee, THINKING: THE ROLE OF DOPAMINE Henk van Steenbergen and Bernhard Hommel
Rebecca Henry, FAAH-MEDIATED MODULATION OF Daniel Kerr, TLR3-INDUCED NEUROINFLAMMATION P3-10 David P. Finn IN THE RAT HIPPOCAMPUS and Michelle Roche
TIME COURSE CHANGES OF CB1 AND Ana Belen Lopez-Rodriguez, CB2 RECEPTORS AFTER TRAUMATIC Estefania Acaz-Fonseca, BRAIN INJURY IN MALE AND FEMALE P3-11 Luis M. Garcia-Segura MICE: STRUCTURAL AND FUNCTIONAL and Maria-Paz Viveros CORRELATES
TOPIC I. Cannabinoid Genetics
Kateřina Tejkalová THE SATIVA-INDICA DILEMMA P3-12 and Arno Hazekamp
Andrea Di Francesco, Anastasia Falconi, Clara Di Germanio, Carlo Cifani, Maria Vittoria EFFECTS OF EXTRA VIRGIN Micioni Di Bonaventura, OIL PHENOLIC COMPOUNDS ON Monica Bari, Stefano Caramuta, P3-13 CB1 GENE EXPRESSION: A ROLE Michele Del Carlo, Dario FOR EPIGENETIC MECHANISMS Compagnone, Enrico Dainese, Claudio D'Addario and Mauro Maccarrone
DEVELOPMENT OF A FLOW CYTOMETRY-BASED BRET ASSAY Morag Rose Hunter, UTILISING GENETICALLY-ENCODED Stephen G Edgar P3-14 BIOSENSORS FOR MIXED CELL and Michelle Glass POPULATIONS: APPLICATION TO CANNABINOID CB1 RECEPTORS
Pamela Prini, ADOLESCENT THC EXPOSURE INDUCES Zamberletti Erica, Gabaglio EPIGENETIC CHANGES AND ALTERS P3-15 Marina, Parolaro Daniela GENE EXPRESSION IN THE RAT and Rubino Tiziana PREFRONTAL CORTEX
TOPIC J. Focus on CB2
Zebing Huang, Ming Gao, SELECTIVE ACTIVATION OF CB2RS Zhengxiong Xi, ELIMINATES AGONIST-INDUCED CA2+ Qingrong Liu, SIGNALS IN PANCREATIC ACINAR P3-16 Xuegong Fan CELLS: A NOVEL CELLULAR and Jie Wu MECHANISM FOR ACUTE PANCREATITIS THERAPEUTICS
Bernhard Reis, Jeremy Beauchamp, Jürgen Fingerle, Uwe Grether, Hugues Matile, A NEW ANTI MOUSE CB2 Matthias Nettekoven, Mark ANTIBODY SENSITIVE TO P3-17 Rogers-Evans, Stephan Röver, RECEPTOR CONFORMATION Sannah Jensen-Zoffmann and Christoph Ullmer
Valeria Gasperi, Daniela Evangelista, Valerio Chiurchiù, 2-ARACHIDONOYLGLYCEROL Fulvio Florenzano, Isabella PROMOTES LEUKOCYTE RECRUITMENT P3-18 Savini, Sergio Oddi, Luciana THROUGH CB1 AND CB2 RECEPTORS Avigliano, M. Valeria Catani and Mauro Maccarrone
Joel Sardinha, CANNABINOID 2 Melanie Kelly, Juan Zhou RECEPTOR MODULATION P3-19 and Christian Lehmann IN EXPERIMENTAL SEPSIS
James Toguri, C. Lehmann, R. Laprairie, A. Bagher, CB2R MODULATION OF LPS-INDUCED A.M. Szczesniak, TOLL-LIKE RECEPTOR 4 SIGNALLING P3-20 E. Denovan-Wright IN OCULAR INFLAMMATION and M.E.M. Kelly
CANNABINOID RECEPTOR 2: A NOVEL Anna-Maria Szczesniak, IMMUNOSUPPRESIVE TARGET IN Heather B. Bradshaw P3-21 EXPERIMENTAL PROLIFERATIVE and Melanie E.M. Kelly VITREORETINOPATHY
Christa van Kralingen, ASSESSMENT OF CB2 IN HUMAN BRAIN David Findlay, Michelle Glass P3-22 TISSUE USING IN SITU HYBRIDISATION and E Scott Graham
DIFFERENTIAL EXPRESSION AND Kristina Burkert, Dan Ting FUNCTION OF THE CB2 RECEPTOR IN Kho, Catherine E Angel, DISTINCT SUBSETS OF HUMAN P3-23 Michelle Glass MONOCYTES AND MACROPHAGES and E Scott Graham FROM BLOOD
Carmen Vázquez, Concepción García, Rosa María Tolón, NEW MOUSE MODEL FOR THE STUDY P3-24 Bonnie Dittel, Julián Romero OF CB2 CANNABINOID RECEPTORS and Cecilia Hillard
TOPIC K. Beyond THC: Cannabidiol and Other Components
NON-PSYCHOACTIVE PHYTOCANNABINOIDS FOR THE Daniel I. Brierley, TREATMENT OF CANCER ANOREXIA- Benjamin J. Whalley P3-25 CACHEXIA SYNDROME: EVIDENCE FOR and Claire M. Williams THE THERAPEUTIC POTENTIAL OF CANNABIGEROL
Tiziana Bisogno, Alberto Rainer, RELEASE OF N-ACYLETHANOLAMINES Pamela Mozetic, Vincenzo BY BIOMATERIALS OF CLINICAL P3-26 Di Marzo, Marcella Trombetta RELEVANCE and Mauro Maccarrone
CANNABIDIOL ATTENUATES SCHIZOPHRENIA-LIKE EFFECTS Felipe V. Gomes, Elaine Del- AND CHANGES ON PARVALBUMIN Bel, Maria-Paz Viveros EXPRESSION IN THE MEDIAL P3-27 and Francisco S. Guimarães PREFRONTAL CORTEX INDUCED BY ANTAGONISM OF NMDA RECEPTORS IN MICE
CHARACTERIZATION OF STRUCTURAL Kazuhito Watanabe, Satoshi REQUIREMENTS FOR POTENT Yamaori, Yoshimi Okushima P3-28 MECHANISM-BASED INHIBITION OF and Ikuo Yamamoto HUMAN CYP1A1 BY CANNABIDIOL
Amanda Wheal, IN VIVO CANNABIDIOL TREATMENT ENHANCES VASORELAXATION TO Michael Randall ACETYLCHOLINE AND SODIUM P3-29 and Saoirse O'Sullivan NITROPRUSSIDE IN ARTERIES FROM ZUCKER DIABETIC RATS
Nagat El Demerdash, M Ruth TEMPORARY THERAPEUTIC WINDOW Pazos, Maria Ceprian, Laura OF CANNABIDIOL FOR P3-30 Jimenez, Ola Didrik Saugestad NEUROPROTECTION AFTER BRAIN and Jose Martinez- Orgado HYPOXIA-ISCHEMIA IN NEWBORN MICE
THE EFFECT OF CBD, CBG, Prathibha M Daniel, AND THCV ON UWB1.289, A HUMAN Roger M. Phillips NON-HORMONE DEPENDANT P3-31 and Farideh A Javid OVARIAN CARCINOMA CELL LINE
Neta Rimmerman, Sarah Atkins, Sheila Langier, CANNABIDIOL REDUCES Emma Leishman, Heather B. INFLAMMATORY AIRWAY IMMUNE P3-32 Bradshaw, Ewa Kozela, CELL ACCUMULATION IN A MOUSE Ana Juknat, Shmuel Kivity MODEL OF ALLERGIC ASTHMA and Zvi Vogel
CANNABIDIOL ACTIVATES GLYCOGEN XiaoQian Liu, Leyu Shi SYNTHASE KINASE IN NEURONS: P3-33 and Cecilia J. Hillard EVIDENCE FOR MEDIATION BY CHANGES IN CELLULAR REACTIVE OXYGEN SPECIES
William Hind, PHARMACOLOGICAL PROPERTIES OF Maria Grazia Cascio, PURE CANNABICHROMENE AND P3-34 Roger Pertwee CANNABICHROMENE BOTANICAL and Marnie Duncan DRUG SUBSTANCE
Leo Ayerakwa, Colin Stott, Marnie Duncan, EVALUATION OF THE GENOTOXICITY P3-35 Stephen Wright OF CANNABIDIOLIC ACID and Geoffrey Guy
Marnie Duncan, PHARMACOLOGICAL PROPERTIES Maria G Cascio, OF PURE CANNABIGEROL AND Roger Pertwee, P3-36 CANNABIGEROL BOTANICAL DRUG Gernot Reidel, Naoki Amada SUBSTANCE and Yuki Yamasaki
THE PHYTOCANNABINOID, Maria Grazia Cascio, Δ9-TETRAHYDROCANNABIVARIN, Erica Zamberletti, CAN ACT THROUGH 5-HT1A P3-37 Pietro Marini, Daniela Parolaro RECEPTORS TO PRODUCE and Roger G. Pertwee ANTI-PSYCHOTIC EFFECTS
Nicholas Jones, Isabelle Pérès, THE PHYTOCANNABINOID Rebecca Hadid, Naoki Amada, CANNABIDIVARIN DEMONSTRATES Charlotte Hill, NOTABLE ANTIEPILEPTIC P3-38 Ahlam Alhusaini, Andy Hill, PROPERTIES AND IS A GENUINE Claire Williams CANDIDATE FOR THE TREATMENT and Ben Whalley OF TEMPORAL LOBE EPILEPSY
PHARMACOLOGICAL PROPERTIES, PHARMACOKINETICS AND Nicholas Jones, BIOAVAILABILITY OF PURE Leo Ayerakwa, Colin Stott P3-39 CANNABIDIOLIC ACID AND and Marnie Duncan CANNABIDIOLIC ACID BOTANICAL DRUG SUBSTANCE
THE NON-PSYCHOTROPIC PLANT Fabio A. Iannotti, CANNABINOIDS, CANNABIDIVARIN Charlotte L. Hill, Antonio Leo, (CBDV) AND CANNABIDIOL (CBD), Camille Soubrane, ACTIVATE AND DESENSITIZE Enrico Mazzarella, TRANSIENT RECEPTOR POTENTIAL P3-40 Emilio Russo, VANILLOID 1 (TRPV1) CHANNELS IN Benjamin J. Whalley, VITRO: POTENTIAL FOR THE Vincenzo Di Marzo TREATMENT OF NEURONAL and Gary J. Stephens HYPEREXCITABILITY
INFLUENCE OF HEPATIC METABOLISM Cristoforo Silvestri, OF Δ9-TETRAHYDROCANNABIVARIN Andrea Martella, (THCV) AND CANNABIDIOL (CBD) P3-41 Marnie Duncan ON THEIR ANTI-STEATOTIC and Vincenzo Di Marzo ACTIONS IN VITRO
M.R. Pazos, H. Lafuente, N. Mohamed, M. Ceprian, ADDITIVE NEUROPROTECTIVE EFFECT M. Santos, L. Arruza, OF CANNABIDIOL AND HYPOTHERMIA P3-42 F.J. Alvarez Diaz IN HYPOXIC-ISCHEMIC PIGLETS and J. Martínez-Orgado
Copyright 2014 © International Cannabinoid Research Society